Multiple Sclerosis Drugs Market: Size, Growth and 2033 Forecast
The global Multiple Sclerosis Drugs Industry encompasses disease-modifying therapies (DMTs), high-purity monoclonal antibodies, oral immunomodulators, and injectable corticosteroid formulations engineered for neurology and immunology.
The global Multiple Sclerosis Drugs Market Size was valued at US$ 21.69 billion in 2025 and is projected to reach US$ 54.04 billion by 2033, growing at a...
